… and evaluation of biomarkers mimicking drug development, … the status of prostate cancer
biomarkers currently in use or under … The keywords included prostate cancer and biomarkers or …

… Prostate-specific antigen (PSA) is a useful, though not specific, biomarker for detecting
prostate cancer. We review the literature on prostate cancer biomarkers, including serum markers …

… There is thus an urgent need to search for novel CaP biomarkers to improve the early detection
… CaP biomarkers and focus on novel identified biomarkers for CaP early diagnosis and …

… biomarkers for early diagnosis of PCa in order to distinguish patients from healthy populations,
which helps guide an early … describes the current early diagnostic biomarkers of PCa in …

… tumor biomarkers than PSA to improve the early diagnosis … , hereditary prostate cancer 1
(HPC1), prostate cancer antigen 3 (… ), early prostate cancer antigen (EPCA), and sarcosine. …

… would be capable of distinguishing PC from benign prostate conditions and differentiating
… in biomarker screening assays. An overview of the emerging prostate cancer biomarkers …

… Prostate cancer (PCa) is the second most common cancer in men worldwide. A large …
progress and which would benefit from an early radical treatment. Prostate-specific antigen (PSA) …

… in expression between normal prostate and cancerous prostate tissues will be … of prostate
cancer biomarkers, we will describe the criteria used when selecting potential biomarkers for …

… Prostate cancer antigen 3 (PCA3) is a biomarker currently commercially available as a … is
only expressed in the prostate, and can be detected in urine and prostatic fluid. Whilst this does …

… Emerging prostate cancer molecular biomarkers noted in this review are beginning to
play an important role in improving diagnosis and treatment. The good news is that there is …